Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing
Applications

Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing

4 min read

Nanosuspensions ? submicron colloidal dispersions of pu […]

Nanosuspensions ? submicron colloidal dispersions of pure drug particles stabilized by surfactants ? are one of the most effective formulation strategies for poorly water-soluble drugs. High pressure homogenization (HPH) is the preferred manufacturing method for industrial-scale nanosuspension production.

This guide covers the process, formulation, optimization, and scale-up of nanosuspensions using HPH.

Why Nanosuspensions?

Pharmaceutical high pressure homogenizer for nanosuspension and drug nanocrystal manufacturing
Pharmaceutical-grade high pressure homogenization for nanosuspension and drug nanocrystal production
Approximately 40% of new chemical entities (NCEs) are poorly water-soluble. Nanosuspensions solve this by reducing drug particle size to the submicron range (< 1000 nm), dramatically increasing surface area and dissolution rate.

Benefit Mechanism
Increased dissolution rate Noyes-Whitney equation: larger surface area ? faster dissolution
Improved bioavailability Smaller particles ? higher saturation solubility
Reduced food effect Absorption less dependent on bile salts
Higher drug loading No carrier matrix (vs liposomes or nanoparticles)
Versatile administration Oral, intravenous, pulmonary, topical

HPH Method for Nanosuspension Production

The Process

Drug powder (micronized, < 100 ?m)
        ?
Pre-suspension preparation (drug + stabilizer + water)
        ?
High shear mixing (5?10 min)
        ?
HIGH PRESSURE HOMOGENIZATION (3?20 passes)
        ?
Particle size analysis (DLS / laser diffraction)
        ?
Final nanosuspension (50?500 nm, PDI < 0.3)

Optimal Parameters

Parameter Typical Range Notes
Pressure 1000?2000 bar Higher pressure ? faster size reduction
Number of passes 10?20 More passes ? smaller size and narrower PDI
Drug concentration 1?10% w/w Higher concentration ? needs more passes
Stabilizer level 0.1?2% w/w Optimize ratio to drug
Temperature 5?25 ?C Keep below drug melting point

Formulation: Drug and Stabilizer Selection

Which Drugs Are Suitable?

  • Poorly water-soluble BCS Class II and IV compounds
  • Drugs with high melting point (> 150 ?C)
  • Compounds stable in aqueous suspension
  • Examples: itraconazole, griseofulvin, naproxen, glibenclamide, fenofibrate

Stabilizer Selection

Stabilizer Type Examples Mechanism
Polymeric HPMC, PVP, HPC Steric stabilization
Surfactant Polysorbate (Tween 80), Poloxamer (Pluronic F68/F127) Electrostatic + steric
Combined PVP + SLS (sodium lauryl sulfate) Synergistic effect

Stabilizer-to-Drug Ratio:
– Typical range: 1:20 to 1:2
– Too little stabilizer ? aggregation
– Too much stabilizer ? toxicity, foaming

Particle Size Reduction Profile

Typical size reduction during HPH processing:

Number of Passes Mean Particle Size PDI
0 (pre-suspension) 10?50 ?m > 0.5
3 500?800 nm 0.3?0.5
6 300?500 nm 0.2?0.4
10 200?400 nm 0.2?0.3
15 150?300 nm 0.1?0.25
20 100?250 nm < 0.2

Scale-Up Considerations

Nanosuspension production with HPH scales linearly. The same pressure and process parameters work across scales.

Scale Smallnm Model Batch Size Throughput
Lab R&D PTH-10 0.1?2 L 10 L/h
Pilot PTH-20 2?10 L 20 L/h
Production 500L/h 50?200 L 500 L/h
Production 1000L/h 200?500 L 1000 L/h

Browse Smallnm Homogenizers

Scale-Up Tips

  1. Maintain constant pressure and pass count across scales
  2. Use the same valve type (seated flat valve recommended for nanosuspensions)
  3. Monitor product temperature ? production runs generate more heat
  4. Consider recirculation mode for multi-pass processing

Quality Control for Nanosuspensions

Test Method Target
Particle size Dynamic light scattering (DLS) 100?500 nm
Polydispersity index DLS < 0.3
Zeta potential Electrophoretic light scattering >
Crystalline state X-ray diffraction (XRD) No amorphization
Drug content HPLC 95?105% of target
Physical stability Visual / particle size over time No aggregation for 3+ months

Comparative Methods

Method Particle Size Scalability Residue / Contamination
HPH 100?500 nm Excellent None (no milling beads)
Wet ball milling 100?500 nm Good Bead erosion (metal/cross-linked polymer)
Precipitation 50?500 nm Moderate Organic solvent residue
Microfluidizer 80?500 nm Good None

HPH offers the advantage of no milling bead contamination ? critical for pharmaceutical products.

Frequently Asked Questions

Can high pressure homogenizer make nanosuspensions?

Yes. HPH is one of the primary methods for nanosuspension (drug nanocrystal) production, achieving particle sizes of 100?500 nm.

How does HPH nanosuspension differ from wet ball milling?

HPH uses no milling beads ? eliminating the risk of bead erosion contamination. HPH also requires fewer passes to reach target size for many drugs.

What pressure is needed for nanosuspension preparation?

1000?2000 bar. More challenging drugs (higher melting point, harder crystals) need higher pressure.

How many passes are needed?

10?20 passes are typical. The optimal number depends on the drug’s mechanical properties and target particle size.

What stabilizers are commonly used in nanosuspensions?

PVP (K-30, K-90), HPMC, Poloxamer 188/407, and SLS are common. A combination of a polymeric stabilizer and a surfactant often gives the best results.

Internal Links

Smallnm high pressure homogenizers for nanosuspension manufacturing ? from lab R&D to commercial GMP production. CE certified, global support.

{ "@context": "https://schema.org", "@graph": [ { "@type": "Organization", "@id": "https://smallnm.com/#organization", "name": "Smallnm", "url": "https://smallnm.com", "logo": { "@type": "ImageObject", "@id": "https://smallnm.com/#logo", "url": "https://smallnm.com/wp-content/uploads/2025/11/cropped-s.png", "contentUrl": "https://smallnm.com/wp-content/uploads/2025/11/cropped-s.png", "caption": "Smallnm", "inLanguage": "en", "width": "512", "height": "512" } }, { "@type": "WebSite", "@id": "https://smallnm.com/#website", "url": "https://smallnm.com", "name": "Smallnm", "publisher": { "@id": "https://smallnm.com/#organization" }, "inLanguage": "en" }, { "@type": "BreadcrumbList", "@id": "https://smallnm.com/nanosuspension-homogenizer/#breadcrumb", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "https://smallnm.com", "name": "Home" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "https://smallnm.com/nanosuspension-homogenizer/", "name": "Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing" } } ] }, { "@type": "WebPage", "@id": "https://smallnm.com/nanosuspension-homogenizer/#webpage", "url": "https://smallnm.com/nanosuspension-homogenizer/", "name": "Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing - Smallnm", "datePublished": "2026-06-03", "dateModified": "2026-06-03", "isPartOf": { "@id": "https://smallnm.com/#website" }, "inLanguage": "en", "breadcrumb": { "@id": "https://smallnm.com/nanosuspension-homogenizer/#breadcrumb" } }, { "@type": "BlogPosting", "headline": "Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing - Smallnm", "datePublished": "2026-06-03", "dateModified": "2026-06-03", "author": { "@type": "Person", "name": "Yves", "url": "https://smallnm.com/author/jkajdmflowo/" }, "publisher": { "@id": "https://smallnm.com/#organization" }, "description": "Complete guide to nanosuspension preparation using high pressure homogenizer. Drug nanocrystal production for poorly soluble APIs.", "name": "Nanosuspension Preparation by High Pressure Homogenizer ? Drug Nanocrystal Manufacturing - Smallnm", "@id": "https://smallnm.com/nanosuspension-homogenizer/#richSnippet", "isPartOf": { "@id": "https://smallnm.com/nanosuspension-homogenizer/#webpage" }, "inLanguage": "en", "mainEntityOfPage": { "@id": "https://smallnm.com/nanosuspension-homogenizer/#webpage" } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Can high pressure homogenizer make nanosuspensions?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. HPH is one of the primary methods for nanosuspension (drug nanocrystal) production, achieving particle sizes of 100?500 nm." } }, { "@type": "Question", "name": "How does HPH nanosuspension differ from wet ball milling?", "acceptedAnswer": { "@type": "Answer", "text": "HPH uses no milling beads ? eliminating the risk of bead erosion contamination. HPH also requires fewer passes to reach target size for many drugs." } }, { "@type": "Question", "name": "What pressure is needed for nanosuspension preparation?", "acceptedAnswer": { "@type": "Answer", "text": "1000?2000 bar. More challenging drugs (higher melting point, harder crystals) need higher pressure." } }, { "@type": "Question", "name": "How many passes are needed?", "acceptedAnswer": { "@type": "Answer", "text": "10?20 passes are typical. The optimal number depends on the drug's mechanical properties and target particle size." } }, { "@type": "Question", "name": "What stabilizers are commonly used in nanosuspensions?", "acceptedAnswer": { "@type": "Answer", "text": "PVP (K-30, K-90), HPMC, Poloxamer 188/407, and SLS are common. A combination of a polymeric stabilizer and a surfactant often gives the best results. ---" } } ] } ] }

Tags

#nanosuspension homogenizer

Written by

Related Articles